About Event
About the 3rd Applied Biocatalysis Summit
The Dedicated Forum For Opening the Doors to New Enzyme-Enables Chemistries for Process
Ready & Scalable Synthesis
With rapid progress in novel enzyme discovery techniques and the demand for greener synthetic routes at an all time high, biocatalysis is fast being prioritized as biopharma, API and fine chemical industry’s synthetic route of choice. In 2023, attendees, joined 80+ Biocatalysis, Process Chemistry & Development experts at the 3rd Applied Biocatalysis Summit to open the doors to carbon footprint-reducing reactions and expedited process scaling strategies.
2023 Agenda Highlights Included:
20+ Expert Presenters, including expertise from Pharma, Biotech, Academia & Enzyme Discovery trailblazers
2 Deep Dive Workshops, to collaboratively address barriers to industry adoption & GMP strategies alongside peers from diverse organisational backgrounds
Gain recognition and take your learnings further attending the Poster & Networking Session to present and discover where ground-breaking research is broadening biocatalysis’ industrial capabilities
Unmissable case-studies addressing the newest innovations and strategies in the potential of AI/ML screening, horizons beyond small molecules and chemoenzymatic catalysis with maximised functionality
Comprehensive coverage of enzyme discovery and engineering including new-to-nature approaches, to bring process ready enzymes to scale quickly to commercial manufacture
Who Attended?
The Experts who joined us in 2023 included:
"I am looking forward to the 3rd Annual Applied Biocatalysis Summit to promote the adoption of biocatalysis in pharmaceutical manufacturing. As biocatalysis becomes more ubiquitous in the industry I can imagine that chemists will reach for biocatalytic screening kits as quickly as they do currently with chemo selective kits!"
Brenden Derstine, Senior Scientist, Chemical Development,
Neurocrine Biosciences
"I would like to make the audience aware of the usefulness of AI/ML technology in biocatalytic research, and look for clues for collaboration"
Michihiro Araki,
Project leader, Deputy Director,
National Institutes of Biomedical Innovation, Health & Nutrition
"Previous years of this conference have been filled with an excellent blend of industry application, new academic directions, and appropriate level of vendor interaction. I attended in-person the 2022 conference (my 1st in-person conference since the pandemic!) and it was eye opening for me to see how rapidly advances were occurring in the field of biocatalysis! The learning and networking enabled my team to make critical strategic changes in our own operation to ensure that we are technologically in-pace with other industry leaders. I am also looking forward to presenting work in the field from my team as well as seeing a number of excellent talks from prominent members in the field! "
Adrian Ortiz, Director of Process Development,
Amgen